Acorah Software Products - Accounts Production 16.3.350 false true true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 5601586 D P Bryant T J Bryant T J Bryant iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 5601586 2024-03-31 5601586 2025-03-31 5601586 2024-04-01 2025-03-31 5601586 frs-core:CurrentFinancialInstruments 2025-03-31 5601586 frs-core:ShareCapital 2025-03-31 5601586 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 5601586 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 5601586 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 5601586 frs-bus:SmallEntities 2024-04-01 2025-03-31 5601586 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 5601586 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 5601586 frs-bus:Director1 2024-04-01 2025-03-31 5601586 frs-bus:Director2 2024-04-01 2025-03-31 5601586 frs-bus:CompanySecretary1 2024-04-01 2025-03-31 5601586 frs-countries:EnglandWales 2024-04-01 2025-03-31 5601586 2023-03-31 5601586 2024-03-31 5601586 2023-04-01 2024-03-31 5601586 frs-core:CurrentFinancialInstruments 2024-03-31 5601586 frs-core:ShareCapital 2024-03-31 5601586 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 5601586
Bryant Pharmacy Limited
Financial Statements
For The Year Ended 31 March 2025
Brian Pittwood
Chartered Certified Accountants
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 5601586
2025 2024
Notes £ £ £ £
CURRENT ASSETS
Cash at bank and in hand 33,639 60,733
33,639 60,733
Creditors: Amounts Falling Due Within One Year 4 (517 ) (390 )
NET CURRENT ASSETS (LIABILITIES) 33,122 60,343
TOTAL ASSETS LESS CURRENT LIABILITIES 33,122 60,343
NET ASSETS 33,122 60,343
CAPITAL AND RESERVES
Called up share capital 5 30 30
Profit and Loss Account 33,092 60,313
SHAREHOLDERS' FUNDS 33,122 60,343
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
D P Bryant
Director
25 April 2025
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Bryant Pharmacy Limited is a private company, limited by shares, incorporated in England & Wales, registered number 5601586 . The registered office is 29 Woodside Road, Parkstone, Poole, Dorset, BH14 9JH.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The company's investment activity ceased on 24 March 2025 and it will be dissolved in April 2025.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Accruals and deferred income 517 390
5. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 30 30
Page 2